Open Access

Sox10- Venus mice: a new tool for real-time labeling of neural crest lineage cells and oligodendrocytes

  • Shinsuke Shibata1,
  • Akimasa Yasuda1, 2,
  • Francois Renault-Mihara1, 2,
  • Satoshi Suyama1,
  • Hiroyuki Katoh1, 2, 3,
  • Takayoshi Inoue4,
  • Yukiko U Inoue4,
  • Narihito Nagoshi1, 2, 3,
  • Momoka Sato1, 2,
  • Masaya Nakamura2,
  • Chihiro Akazawa5 and
  • Hideyuki Okano1Email author
Molecular Brain20103:31

https://doi.org/10.1186/1756-6606-3-31

Received: 23 October 2010

Accepted: 31 October 2010

Published: 31 October 2010

Abstract

Background

While several mouse strains have recently been developed for tracing neural crest or oligodendrocyte lineages, each strain has inherent limitations. The connection between human SOX10 mutations and neural crest cell pathogenesis led us to focus on the Sox10 gene, which is critical for neural crest development. We generated Sox10- Venus BAC transgenic mice to monitor Sox10 expression in both normal development and in pathological processes.

Results

Tissue fluorescence distinguished neural crest progeny cells and oligodendrocytes in the Sox10- Venus mouse embryo. Immunohistochemical analysis confirmed that Venus expression was restricted to cells expressing endogenous Sox10. Time-lapse imaging of various tissues in Sox10- Venus mice demonstrated that Venus expression could be visualized at the single-cell level in vivo due to the intense, focused Venus fluorescence. In the adult Sox10- Venus mouse, several types of mature and immature oligodendrocytes along with Schwann cells were clearly labeled with Venus, both before and after spinal cord injury.

Conclusions

In the newly-developed Sox10- Venus transgenic mouse, Venus fluorescence faithfully mirrors endogenous Sox10 expression and allows for in vivo imaging of live cells at the single-cell level. This Sox10- Venus mouse will thus be a useful tool for studying neural crest cells or oligodendrocytes, both in development and in pathological processes.

Background

The neural crest (NC) is a transient embryonic tissue. NC cells delaminate from the dorsal neural tube as it closes [1] and migrate to distinct locations, where they differentiate into various cell types, including neurons, glia, melanocytes, endocrine cells, and mesenchymal cells [25].

The Sox proteins belong to the HMG (high mobility group) domain of transcription factors [6, 7]. Sox-E is the earliest marker of a subset of cells at the border of the neural plate that will give rise to NC-lineage cells [8]. Sox10, which is a member of the Sox-E family and shares high sequence homology with other Sox-E member transcription factors, regulates and coordinates diverse developmental processes such as organ development and cell survival and specification. Sox10 is highly expressed in the emerging NC and later in the developing glial cells of the peripheral nervous system (PNS) and central nervous system (CNS) [9, 10]. Whether in mice or humans, Sox family protein deletions or mutations often result in developmental defects and congenital disease, and mutations of the human SOX10 gene are associated with NC cell abnormalities [9, 1113].

Several transgenic mouse strains dedicated to tracing the NC lineage have already been developed, such as Wnt1-Cre [14], Protein zero (P0)-Cre [15], and Ht-PA- Cre [16] mice crossed with Cre-dependent reporter mice. The Cre recombinase expression was previously visualized by LacZ, a β-galactosidase reporter gene inserted in the ROSA26 locus, that is expressed only after the loxP-flanked intervening sequence is excised by Cre [17]. Once a specific promoter is activated, the cell is indelibly tagged with β-galactosidase. This kind of transgenic mouse is useful for monitoring the transient activation of various promoters, including the NC-specific promoter. Recently, mouse strains expressing a fluorescence-based reporter upon Cre-mediated conditional gene deletion have been developed for prospective cell sorting or direct observation without fixation [18]; the CAG-CAT-EGFP reporter transgenic mouse strain expresses enhanced green fluorescent protein (EGFP) when the loxP-flanked CAT gene located between the modified chicken β-actin promoter (CAG promoter) and the EGFP gene [18] is excised with Cre. In previous studies, we have used mice that enable Cre/loxP-mediated cell labeling with LacZ or EGFP to analyze the NC lineage and to trace NC cells after their migration and differentiation [5, 1921].

However, for specific gene regulation analysis, transgenic or knock-in mouse lines that express a specific gene profile in vivo are more useful, because the reporter gene is expressed only while the specific promoter or enhancer is active, and ceases when the promoter becomes inactive. Reporter mice have recently been developed to evaluate cell-type specification and maturation in the oligodendroglial lineage; these are the 2'-3'-cyclic nucleotide 3'-phosphodiesterase (CNP)-EGFP and myelin proteolipid protein (PLP)-EGFP transgenic mouse lines [22, 23]. The CNP-EGFP transgenic mouse, in which the CNP promoter controls EGFP expression, has been used for the prospective identification of live oligodendroglial cells both in vivo and in vitro[23]. The PLP-EGFP transgenic mouse, in which EGFP expression is driven by the mouse PLP gene promoter, has also been developed for investigating oligodendrocyte lineage cells without fixation and immunostaining [22].

Sox10 expression is closely related to NC-lineage cells. The Sox10LacZ/+[24], Sox10- rtTA [25], and Sox10- Cre [26] mouse lines have all been reported to label NC cells and oligodendrocytes. Sox10LacZ/+[24], a mutant mouse targeting Sox10, was generated by replacing the open reading frame of Sox10 with lacZ sequences. The Sox10LacZ/+mutation causes haploinsufficiency, in which even heterozygous pups have the phenotype found in mice with a spontaneous mutation in the Sox10 allele. Although LacZ expression in this knock-in strain faithfully reflects the endogenous Sox10 expression, it is difficult to observe normal developmental behavior in the labeled cells because of the abnormal and pathological condition of the Sox10 LacZ/LacZ homozygous mice [24]. Another unique reporter strain is the Sox10- rtTA knock-in mouse [25], in which a variant of the reverse tetracycline-controlled transactivator (rtTA) is inserted into the genomic Sox10 locus, and the mice are crossed with the doxycycline-dependent LacZ reporter line. This strain correctly recapitulates endogenous Sox10 expression in the NC and its derivatives, and also in oligodendrocytes. This inducible transgenic system is limited in its range of analysis, because the reporter gene expression is temporary and requires X-gal staining [25]. The Sox10- Cre transgenic mouse strain, designated as the S4F:Cre mouse, when crossed with the reporter line strain Rosa-LacZ, identifies cells expressing Sox10, including NC-derived cells, oligodendrocytes, and cells in the ventral neural tube [26]. These strains are powerful tools for tracing the progeny of Sox10-expressing cells in analyses of NC cell migration and oligodendroglial differentiation. However, permanent reporter gene expression does not permit the real-time analysis of Sox10 expression. To overcome these limitations, we generated a new Sox10- Venus transgenic mouse, and confirmed that it enables the normal behavior of Sox10-expressing cells to be observed in vivo.

Results

Sox10- Venus BAC transgenic mouse generation

To examine the Sox10 expression profile in vivo, we took advantage of the bacterial artificial chromosome (BAC) transgenic strategy where entire regulatory machinery for a given gene expression might be covered with a single BAC clone. In short, we modified a 225.6 kb-sized BAC clone RP24-85O14 by means of homologous recombination to harbor the coding sequence of the fluorescent Venus protein [27] in-frame to the Sox10 translation initiation codon (ATG) that locates at the middle portion of the clone. This construct yielded seven BAC transgenic founders expressing Venus and we hereafter analyzed the complete expression profile in a particular transgenic founder with the brightest illumination.

First, we evaluated the distribution of Venus fluorescence at each developmental stage of the Sox10-Venus mouse embryo. Venus fluorescence in classical NC lineage tissues was directly visible from outside the embryo by using an epifluorescence microscope and a UV light. At embryonic day 11.5 (E11.5 d), Venus green fluorescence was particularly intense in the dorsal root ganglia (DRG) and the trigeminal ganglia (cranial nerve V) (Figure 1A). We observed that Venus fluorescence was not limited to classical NC lineage tissue, but was also observed in non-NC tissues, including the otic vesicle. This is consistent with previous studies in which in situ hybridization revealed endogenous Sox10 expression in otic vesicle cells [28, 29], which are the primitive state of the vestibulocochlear nucleus (cranial nerve VIII). In the facial area of the E11.5 d embryo, aggregated green cells were observed among scattered Venus-positive cells (Figure 1B). The intensity and resolution of the Venus fluorescence allowed us to observe single cells in a pattern suggestive of the NC cell rostral migration process (arrowheads in Figure 1B). As development proceeded from E11.5 d to E15.5 d, Venus fluorescence from the DRGs and nuclei of the cranial nerves located in deep tissues gradually decreased, due to the thickening dermal layer (Figure 1A, C, and Additional file 1A - 1C). However, migrating Venus+ cells in the superficial layer of the embryonic skin were now detectable from outside the body. Venus fluorescence was observed in the Schwann cells of the neural network stemming from the spinal nerve's posterior branches, and in peripheral sensory nerve fibers (Figure 1D). In the hind limb, the peripheral nerve network and the adjacent vascular network were visible (Figure 1E). Three-dimensional reconstructions of the peripheral nerve fibers displayed the entire neural network in the craniofacial area, which was mainly derived from the branches of the facial nerve (cranial nerve VII) (Figure 1F).
Figure 1

The novel Sox10- Venus transgenic mouse strain. The Sox10- Venus BAC transgenic mouse strain was generated to investigate the Sox10 expression profile in vivo. (A) Venus could be detected in NC lineage tissues, including the DRG and trigeminal ganglia, in E11.5 d mice. Sox10+ cells that were not NC-derived, including cells in the otic vesicle, could also be visualized with Venus. (B) High-intensity fluorescence enabled us to observe a migration stream at the single-cell level, from outside the embryo. (C) At E15.5 d, deep-tissue Venus fluorescence decreased. At this age, migrating Venus+ cells and the network formation of Venus+ cells in the superficial skin layer could be traced. (D) The posterior branches of the spinal nerve were clearly visualized with Venus+ Schwann cells, along with peripheral nerve fibers. (E) In the hind limb, the peripheral nerve and vascular network formations were clearly outlined. (F) The peripheral neural network mainly derived from cranial nerve VII could be visualized with three-dimensional reconstruction with an Olympus MVX-CSU microscope. (G) Time-lapse imaging of the front facial area of embryonic Sox10- Venus mice clearly showed individual Venus+ cell movement (also shown in movies in Additional Files 2 and 3). (B) and (D, E) are high-magnification images of the indicated areas in Figures (A) and (C), respectively. Cranial nerves V, trigeminal nerve; VII, facial nerve; VIII, vestibulocochlear nerve, Scale bars; (A-F) 1.0 mm.

Observing the behavior of individual Sox10- Venus cells

The intensity and resolution of the Venus fluorescence in the new Sox10- Venus mice led us to evaluate whether it was possible to monitor the behavior of individual cells. Time-lapse imaging ex-vivo in skin explants from E14.5 d Sox10- Venus embryos was first performed using an epifluorescence microscope. Within this experimental setup, it was easy to detect and follow the movements of single cells (Figure 1G and the movie in Additional File 2). As Sox10 is expressed in deep tissues during the early stages of development, we next examined whether it would be possible to observe Venus fluorescence in whole Sox10- Venus embryos. Whole embryos at E10.5 d were observed using a confocal microscope, and followed over time. Time-lapse imaging of the front facial area allowed us to monitor the migration of several Venus+ cells within the embryo over a duration of several hours. We were also able to observe the shape dynamics of individual migrating cells (movie in Additional File 3).

Venus fluorescence in frozen sections of Sox10- Venus mice

To confirm the Venus+ cell distribution, we prepared cryosections of Sox10- Venus mice from each embryonic stage and observed the Venus fluorescence directly, without any antibody staining or enhancement procedure (Figure 2). In axial sections of the thoracic region of E15.5 d mouse embryos, Venus fluorescence was intense in the DRG and its proximal and peripheral branches (Figure 2A). Venus+ cells were diffusely present throughout the spinal cord. Some ganglion cells were positive for Venus (Figure 2A, arrows) in the sympathetic ganglia located at the ventral side of the vertebral disc. In horizontal cranial sections from E15.5 d Sox10- Venus embryos, large numbers of Venus+ cells accumulated to form the trigeminal ganglia (cranial nerve V) (Figure 2B). Venus was highly expressed in the ocular nerve, which is the first branch of the trigeminal nerve. Venus+ cells were randomly distributed in the E15.5 d adrenal gland, most likely due to the incomplete column structure formation at this stage (Figure 2C). In the alimentary tract, Venus+ enteric ganglion cells originating from the vagal nerve (cranial nerve XII) were found migrating in a rostrocaudal direction through the esophagus, stomach, midgut, and hindgut (Figure 2D and 2E). All of these tissues are well-known NC derivatives, demonstrating that the Venus fluorescence observed in the Sox10- Venus mice is consistent with known NC cell localization and differentiation [13, 5]. In the otic vesicle, which is the primary structure of the inner ear nerve, cells continuously expressed Venus throughout the embryonic period (Figure 2F and 2G). The otic vesicle is not a NC derivative, but Sox10 protein expression in otic vesicle cells during the embryonic stage has been reported [28, 29].
Figure 2

Venus expression in neural crest lineage tissues and in otic vesicle observed without immunostaining. The distribution of Venus+ cells in Sox10- Venus mice was evaluated in embryonic-stage cryosections. Venus fluorescence was directly observed without immunostaining. (A) On the thoracic region of an E15.5 d axial section, Venus+ cells were localized to the DRG and its central and peripheral branches. In the spinal cord, Venus+ cells were broadly localized to both the gray matter and the white matter. Venus+ sympathetic ganglion cells were also found at the ventral side of the vertebral body (arrows). (B) In an E15.5 d horizontal section of the cranial area, Venus+ cells concentrated and formed the trigeminal ganglia (the nucleus of the V cranial nerve) and its first branch, the ocular nerve, also visualized by Venus. (C) Venus+ cells were randomly localized in the E15.5 d adrenal gland. (D) NC-derived enteric ganglion cells were seen originating from the XII cranial nerve (Nervous Vargus) and migrating in an oral to anal direction in the alimentary tract. (D-E) On the lumbar level axial section, Venus+ cells were captured in the esophagus, stomach, midgut, and hindgut in the stream of their migration. (F-G) The primary structure of the inner ear, designated as the otic vesicle, also expresses Venus in the embryonic period. The otic vesicle is not NC-derived, but expresses Sox10. SC, spinal cord; TG, trigeminal ganglia; AG, adrenal gland; Es, esophagus; St, stomach; Hg, hindgut; Mg, midgut; Ov, otic vesicle. Scale bars (A-C, E) 100 μm, (D, F-G) 50 μm.

Cell type evaluation of the Venus+ cells in Sox10- Venus mice

To verify that the Venus expression correctly reflects the endogenous expression of the Sox10 protein in vivo, we performed immunohistochemistry of E11.5 d to postnatal 1-week-old (P1 w) whole mouse frozen sections. Without exception, in all the tissues and stages examined, all the Sox10-positive cells expressed Venus. In addition to Sox10 immunostaining, we also examined cell-type-specific markers in NC-derived and Sox10+ tissues. The enteric ganglion cells in the alimentary tract stained with PGP9.5 antibodies. In the esophagus, stomach, midgut, and hindgut, most of the migrated enteric ganglion cells were positive for Venus at E15.5 d (Figure 3A). In the E15.5 d adrenal gland stained for tyrosine hydroxylase (TH), a marker for catecholaminergic cells, TH-positive endocrine cells were positive for Venus (Figure 3B). In the early embryonic (E11.5 d) DRG, all Hu-positive sensory neurons were co-labeled with Sox10 and Venus (Figure 3C). These observations confirmed that Sox10- Venus is a useful reporter strain, in which Venus expression faithfully reflects the endogenous Sox10 in vivo expression.
Figure 3

Venus expression faithfully reflects endogenous Sox10 expression. Immunohistochemistry was used to confirm the in vivo co-localization of Venus with specific cell-type markers in Sox10- Venus mice. (A-F) All Sox10-positive cells were also positive for Venus; no ectopic Venus expression was detected in an entire series of sections. (A) In the E15.5 d alimentary tract, PGP9.5-positive enteric ganglion cells were also positive for Venus. (B) TH-positive endocrine cells in the E15.5 d adrenal gland were invariably positive for Venus. (C-D) While all Hu-positive early embryonic DRG neurons expressed endogenous Sox10 and Venus protein at E11.5 d, mature DRG neurons lost the Sox10 and Venus expression simultaneously at E15.5 d, and Sox10+ satellite cells became positive for Venus. (E-F) In the embryonic sympathetic ganglia, all the TH+ neurons were also Venus+ at E11.5 d, whereas TH+/Venus- cells appeared at E15.5 d. Hu+, terminally differentiated neuron; PGP9.5+, enteric ganglion cell; TH+, adrenal gland endocrine cells and sympathetic ganglion neurons; epi, epithelium. Scale bars (A-F) 50 μm.

Loss of Venus-fluorescence correlates with the shutdown of endogenous Sox10 expression

To evaluate the on/off switching of reporter gene activity in Sox10- Venus mice, we verified the Sox10 expression with immunohistochemistry, and examined its correlation with Venus fluorescence. At the late embryonic stage of E15.5 d, the loss of Sox10 expression in Hu-positive DRG neurons coincided with a dramatic decrease in Venus fluorescence, compared to the early embryonic stage (Figure 3C and 3D). A similar phenomenon was observed in embryonic sympathetic ganglia: most of the TH+ neurons were Venus+ in the early embryonic stage, while TH+ neurons in the late embryonic stage lost both Venus and Sox10 expression (Figure 3E and 3F).

The prompt on/off switching of reporter gene activity is an important characteristic of this transgenic mouse strain. In mice in which the NC lineage is labeled, such as the Wnt1-Cre/CAG-CAT-EGFP double transgenic mouse, NC progeny expressing Cre are indelibly labeled with the reporter gene. At the late embryonic stage of E15.5 d, neurons in the DRG and sympathetic ganglia of Wnt1-Cre/CAG-CAT-EGFP mice were still labeled with EGFP fluorescence even though endogenous Sox10 expression had already diminished (Additional file 4). In contrast, the sensitive on-off switching of the Venus-fluorescent reporting makes the Sox10- Venus mouse an accurate, real-time reporter strain.

Identification of Venus+ cells in the intact embryonic spinal cord

Previous reports have suggested that Sox10 is expressed in oligodendrocyte progenitor cells (OPCs) and mature oligodendrocytes [2426]. We examined the identity of the Venus+ cells observed in the ventral region of the intact embryonic spinal cord of Sox10- Venus mice by immunohistochemistry. The Venus+ cells were negative for the pan-neuronal marker Hu (Figure 4A), but positive for the oligodendroglial-lineage markers GSTπ and Olig2 (Figure 4B and 4C). Therefore, in the spinal cord of the embryonic Sox10- Venus mouse, Venus labels oligodendroglial-lineage cells without distinction as to their degree of maturation.
Figure 4

Sox10- Venus + cells in the intact embryonic spinal cord. Immunohistochemical analysis of Venus+ cells in the intact embryonic spinal cord of Sox10- Venus mice. (A) Venus fluorescence did not colocalize with the pan-neuronal marker Hu in the ventral area of Sox10- Venus mice. (B-C) These Venus+ cells expressed the oligodendroglial lineage markers GSTπ and Olig2, showing that the Venus+ cells were OPCs and mature oligodendrocytes. Scale bars; (A-C) 50 μm.

Venus+ cells in the intact and injured spinal cords of adult Sox10- Venus mice

To examine the phenotype of Venus+ cells in intact and injured spinal cords of Sox10- Venus mice, we first observed changes in the Venus+ cells over time (Figure 5A - C). After spinal cord injury (SCI), there was a sharp drop in the number of Venus+ cells, followed by a gradual accumulation around the lesion epicenter at later stages after the injury.
Figure 5

Sox10- Venus + cells actively accumulate at the spinal cord injury site. Venus fluorescence illuminated the behavior of Sox10- expressing cells after a spinal cord injury. (A) In an intact adult mouse spinal cord, Venus+ cells were clearly visible in both in the gray and the white matter. (B) In the acute phase of contusive spinal cord injury (4 dpi; days-post-injury), Venus+ cells were absent from the lesion site. (C) In the subacute phase (14 dpi), numerous Venus+ cells were present around the lesion and delineated the lesion epicenter. Scale bars (A-C) 500 μm.

Next, we identified the Venus+ cells in intact and injured spinal cords by immunostaining with various cell markers (Figure 6A - H). In the intact spinal cord, Venus+ cells were easily visualized in both the gray and white matter (Figure 5A), and were mostly positive for GSTπ (Figure 6A). After contusive SCI, Sox10-expressing cells disappeared from the lesion epicenter (Figure 5B). In the acute phase of SCI (4 days-post-injury; 4 dpi), cells positive for NG2 and Venus appeared in the residual white matter (Figure 6B). Although NG2 is also known to stain reactive astrocytes and macrophages [30], the Venus+ cells observed in the injured spinal cord were negative for GFAP (Figure 6D) and CD11b (Figure 6E), indicating that they were Sox10-expressing oligodendrocytes. We also observed Venus+ cells that were positive for PDGFRα, an OPC marker (Figure 6C), suggesting that OPCs also expressed Sox10 in the injured spinal cord.
Figure 6

Immunohistochemical analysis of Sox10- Venus + cells after spinal cord injury. (A-E) OPCs and mature oligodendrocytes were Venus+ in the intact and injured spinal cord of Sox10- Venus mice. (A) Most Venus+ cells were positive for GSTπ in the intact spinal cord. (B) In the acute phase (4 dpi), NG2+ cells increased in the residual white matter in response to the SCI. Some of the NG2+ cells also expressed Venus. (C-E) In the acute phase, Venus+ oligodendroglial cells were also positive for PDGFRα (C), but were negative for GFAP (D) and CD11b (E). (F) In the subacute phase of the SCI (14 dpi), S100β+ cells were also present around the lesion site, and expressed Venus. (G) Some of the Venus+ cells were positive for p75, suggesting that they were immature Schwann cells with bipolar processes. (H) A small number of Venus+ cells were mature Schwann cells, as assessed by Protein Zero expression. Scale bars; (A-E) 20 μm, (F-H) 50 μm.

In the later subacute phase of SCI (14 dpi), numerous Venus+ cells were found in the epicenter and around the lesion site (Figure 5C). Immunohistochemistry revealed that many of the Venus+ cells were positive for S100β, a marker of the Schwann cell lineage, confirming Schwann cell involvement after SCI (Figure 6F). Some of the Venus+ cells had bipolar processes and were positive for p75, suggesting that they were immature Schwann cells (Figure 6G), while a few Venus+ mature Schwann cells were also identified by their P0 expression (Figure 6H). The observation that both immature and mature Schwann cells were Venus+ in the injured spinal cord is consistent with the Schwann cell lineage deriving from the NC.

Comparison of the Sox10- Venus strain with other NC reporter mouse strains

The data from several NC reporter mouse lines, such as Sox10(S4F)-Cre, P0-Cre, Wnt1-Cre, and Ht-Pa-Cre [5, 14, 16, 26, 31, 32], have already been published. To compare this body of data to the observations gained from the Sox10- Venus mouse, the embryonic expression patterns of various NC-derived tissues are summarized for each strain in Table 1. At the early embryonic period (E11.5 d - E12.5 d), the reporter gene activity of all the mouse strains was quite similar. All the strains demonstrated reporter gene activity in numerous NC-lineage tissues, including the DRG, sympathetic ganglia, melanoblasts, enteric nervous system, superior/jugular ganglion, aorta, and craniofacial mesenchyme. All the strains also showed reporter expression in the otic vesicle, which does not originate from the NC.
Table 1

Comparison of reporter expression in Sox10 - Venus and various other mice with NC lineage-labeling

Tissues

Sox10-Venus

Sox10-Cre

P0-Cre

Wnt1-Cre

Ht-Pa- Cre

Dorsal root ganglia

+

+

+

+

+

Sympathetic ganglia

+

+

+

+

+

Melanoblasts

+

+

+

+

+

Enteric nervous system

+

+

+

+

+

Superior/jugular ganglion

+

+

+

+

+

Aortae

+

+

+

+

+

Craniofacial mesenchyme

+

+

+

+

+

Otic vessicle

+

+

+

+

+

Oligodendroglia

+

+

-

-

-

Ventral neural tube

+

+

-

-

-

Developing limb

+

+

-

-

-

Reporter gene expression patterns at the embryonic stage are compared in various mice developed to trace neural crest derivatives: Sox10- Venus, Sox10(S4F)-Cre [26], P0-Cre [5, 15], Wnt1-Cre [14, 16, 26, 31, 32], and Ht-Pa- Cre [16, 26]. All these lines have similar labeling patterns in both NC-lineage tissues (DRG, sympathetic ganglia, melanoblasts, enteric nervous system, superior/jugular ganglion, aorta, craniofacial mesenchyme) and in tissues not in the NC lineage (otic vesicle, oligodendroglial cells, and OPCs). In the developing limbs of Sox10- Venus and Sox10- Cre mice, which reflect the endogenous Sox10 expression profile, the reporter fluorescence clearly labeled oligodendroglial cells and the peripheral nervous network. Immunohistochemistry did not detect any ectopic reporter gene expression in any tissues from the embryonic Sox10- Venus mice.

Regarding the differences in these reporter strains, CNS myelinating glial cells were not labeled in the P0-Cre, Wnt1-Cre, and Ht-Pa-Cre strains; they were only labeled in the Sox10-related strains Sox10- Venus and Sox10(S4F)-Cre. In the brain and spinal cord, the labeling of oligodendroglial cells and OPCs in the Sox10- Venus and Sox10- Cre mice reflected the endogenous Sox10 expression in these cells, since they are not derived from the NC. The peripheral nerve network in developing limbs consists of nerve fibers and their associated Schwann cells, which are both derived from the NC. Although the LacZ expression in the developing limb was ambiguous in the Sox10(S4F)-Cre/Rosa-LacZ mouse [26], the Venus fluorescence observed in the same region with the Sox10- Venus mouse clearly originated from the Schwann cells (Figure 1E).

Discussion

In this study, we developed and characterized the Sox10- Venus BAC transgenic mouse. Analysis of the early embryonic stages showed that not only NC lineage cells, but also oligodendroglial cells were clearly labeled with high-intensity Venus fluorescence (Figure 1 and 2). Compared to other published transgenic and knock-in reporter mouse strains, the Sox10- Venus mouse has advantages that make it invaluable for future studies.

The mice with NC-lineage tracing Wnt1-Cre, P0-Cre, and Ht-PA-Cre, crossed with those with Cre/loxP-mediated cell labeling, Rosa-LacZ and CAG-CAT-EGFP, can be used only for analyzing cell lineage or migration, because the target cells are irreversibly labeled [5, 1420]. Although Sox10- Venus also labels NC-lineage cells, the fast on/off switching of Venus fluorescence is tightly correlated with endogenous Sox10 expression. Similarly, the reporter gene activity in CNP- EGFP and PLP- EGFP mice, which are transgenic mice that label oligodendroglial-lineage cells, truly reflects the in vivo expression of specific genes driven by specific promoters or enhancers. The transgenic system of the Sox10- Venus mouse is quite similar to these; however, the Venus fluorescence is brighter and more intense than EGFP fluorescence.

Although reporter gene activity occurs in NC cells and oligodendrocytes in all Sox10 reporter mouse lines, i.e., Sox10 LacZ/+ , Sox10- rtTA, Sox10- Cre strains [2426], and the new Sox10- Venus strain, each line has advantages and disadvantages. LacZ knock-in Sox10LacZ/+heterozygous pups are prone to spontaneous mutation phenotypes due to haploinsufficiency. Also, to observing the LacZ expression in Sox10LacZ/+mice requires additional visualization procedures, making live cell imaging difficult. The Sox10- rtTA knock-in crossed with the inducible TRE-LacZ transgenic is unique, but the reporter expression is transient and does not fluoresce, making it difficult to observe directly. The Sox10- Cre/CAG-CAT-EGFP double transgenic mouse traces both NC and oligodendrocyte progeny, since it reports past as well as ongoing Sox10 expression. With this double transgenic mouse, it is possible to carry out cell sorting or live imaging.

The Sox10- Venus strain overcomes most of the disadvantages of the above-mentioned Sox10 reporter mouse lines. In this mouse, the intense Venus fluorescence can be directly observed from outside the embryo, without staining or enhancement procedures (Figure 1, 2, and movies in Additional Files 2 and 3). Venus expression faithfully reflects real-time endogenous Sox10 expression, with prompt on/off switching (Figure 3). Although the choice of strain obviously depends on the purpose of the study, we believe that the Sox10- Venus mouse is the most appropriate reporter line for numerous fields of research.

Although in vivo time-lapse imaging of oligodendroglial cell migration (including OPCs) has recently been reported, it has only been conducted in zebrafish [33, 34]. Accurate time-lapse imaging has been difficult to conduct in mice until now. There are several issues that need to be considered in such studies. For instance, (1) Is the normal and natural behavior of the cells or tissues of interest being observed? In some cases, the invasive procedures required to complete the imaging, including surgical incision, tissue-slice culture, electroporation, dye injection, and virus infection, may affect the tissues observed. (2) To what degree does the transgenic manipulation affect the phenotype? In Sox10LacZ/+mice, the resulting phenotype, coupled with haploinsufficiency, complicates analysis of the area of interest. Our analysis of the Sox10- Venus transgenic line demonstrates that it has neither developmental defects nor ectopic Venus expression. Thus, the Sox10- Venus strain appears to be a useful tool for investigating normal developmental processes via live cell monitoring, using directly observed fluorescence without invasive intervention procedures (Figure 1G, movies in Additional Files 2 and 3).

Sox10 is a well-known marker of neural crest stem cells (NCSCs), along with slug, snail, and p75[35, 36]. There have been numerous reports recently of NCSCs surviving in a wide range of tissues through the entire lifespan of the animal, suggesting that NCSCs may have the potential to support the regeneration and recovery of damaged tissues. The Venus fluorescence in Sox10- Venus mice will make it possible to prospectively sort Venus+ cells by flow-cytometry and collect an enriched population of NCSCs. Since NCSCs are located in easily accessible peripheral tissues such as the skin and bone marrow, NCSCs have been receiving increasing attention for future clinical applications in cell transplantation therapy, because the feasibility of autologous transplantation is anticipated [3739]. Autologous cell transplantation therapy avoids the immunological and ethical concerns related to the use of embryonic stem cells. We hope that the Sox10- Venus strain will prove to be a powerful tool for enhancing the progress of NCSC research.

The mouse is an excellent model system for studying human disease progression and pathogenesis. We demonstrated the usefulness of our new reporter mouse strain Sox10- Venus for monitoring processes occurring after a traumatic disorder (Figure 5 and 6), and crossing it with mutant mouse lines may provide insight into the processes behind numerous developmental defects. As with the analysis conducted in CNP-EGFP mice to study the behavior of oligodendroglial cells in SCI [30], Sox10- Venus mice have potential applications not only for oligodendrocyte research, but also for all Sox10+-tissue analyses, including disorders of the NC cells and peripheral nerves. The ability to visualize the processes of disease initiation and progression will help to shed light on the pathophysiology of many human diseases.

Conclusions

We developed the novel Sox10- Venus BAC transgenic mouse line, in which Venus fluorescence labels NC and oligodendroglial lineage cells. Endogenous Sox10 expression is accurately reported by Venus fluorescence over the course of normal development, without ectopic Venus expression. The highly intense reporter fluorescence allows for in vivo imaging of single-cell migration. This strain will be especially useful for analyzing spinal cord injury and studying NCSCs.

Methods

BAC Construction and development of Sox10- venus BAC transgenic mice

For generating the Sox10-Venus transgenic mouse, we prepared the following BAC construction. Detailed procedures will be described elsewhere (CA, TI, YUI, manuscript in preparation). Briefly, a BAC clone RP24-85O14 (CHORI, BACPAC Resources) that covers 225.6 kb territory of mouse Sox10 gene locus was electroporated into the recombinogenic bacterial strain EL250 for systematic modifications [40]. To obtain in-frame replacement of the exon containing the Sox10 translation initiation codon (ATG) to the Venus-polyadenylation signal (pA) cassette in the BAC clone, 1.2 kb homology arms were amplified by PCR and sequentially subcloned into the pBluescriptII vector (Stratagene). Then the Venus-pA-FRT-Kanamycin-resistant gene (Kan r )-FRT cassette was inserted in between the arms and the fragment containing the Venus-pA-Kan r cassette with the homology arms was isolated by agarose gel electrophoresis for homologous recombination which was processed in EL250 as was reported previously [41]. Precise insertion of the Venus-pA cassette and excision of the Kan r in the Sox10-BAC was verified by PCR as well as pulse field gel electrophoresis and the modified BAC clone was linearlized by PI-Sce I, dialyzed and diluted to ~2 ng/μl for pronuclear injections as previously described [41]. For BAC transgenic mouse founders, presence of RP24 BAC vector sequences immediately upstream or downstream of the PI-Sce I site was always examined by PCR tail DNA analyses to minimize the possibility that fortuitous deletions occur on the BAC transgene after the chromosomal integrations [41]. The established BAC transgenic mouse lines were bred with wild-type C57BL/6J mice and the tail DNA was used for the PCR genotyping: The PCR primers for the transgene detections are provided in Table S1; Additional File 5.

Animals

We purchased wild-type C57BL/6J and ICR mice from SLC Japan. The Cre-expressing transgenic lines, Wnt1-Cre [14] and P0-Cre [15], were mated with an EGFP reporter line (CAG-CAT-EGFP [18]) to obtain Wnt1-Cre/CAG-CAT-EGFP and P0-Cre/CAG-CAT-EGFP double-transgenic mice. All mice were housed under specific pathogen-free conditions. All experimental procedures were approved by the Institutional Animal Care and Use Committee of Keio University, Murayama Medical Center, and Tokyo Medical and Dental University. All surgical interventions and animal care procedures were in accordance with the Laboratory Animal Welfare Act, the Guide for the Care and Use of Laboratory Animals (National Institute of Health, USA).

Histological analysis

Immunohistochemical analyses were performed as described previously [5, 42, 43]. Briefly, E9.5 d, n = 3; E10.5 d, n = 10; E11.5 d, n = 9; E12.5 d, n = 5; E13.5 d, n = 6; E14.5 d, n = 3; E15.5 d, n = 7; E16.5 d, n = 3; P0 d, n = 3; and P1 w, n = 3 transgenic embryos (E0 = day of plug) and pups were fixed with 4% PFA, and 16-μm-thick cryosections were prepared with the cryostat CM3000 (Leica). The detailed information about the primary and secondary antibodies was described in Table S1; Additional File 5. Antigen retrieval was applied for specific targets (anti-Olig2, anti-hSox10) by incubating them with Target Retrieval Solution (Dako) in an autoclave at 105°C for 5 minutes. Fluorescence immunostaining with specific primary antibodies was performed overnight at 4°C, followed by one-hour incubation at room temperature with the appropriate secondary antibodies conjugated with Alexa488, Alexa555, or Alexa647 (Invitrogen) along with Hoechst 33258 (10 μg/ml, Sigma) for nuclear staining. The samples were examined with a laser scanning confocal microscope (LSM700 or Pascal: Carl Zeiss) or fluorescent microscope (BZ-9000: Keyence, MVX-CSU: Olympus).

Time-Lapse Imaging

Time-lapse observation (Figure 1G, movies in Additional Files 2 and 3) was performed as described previously [44, 45]. Briefly, freshly isolated embryos were collected in cold phosphate buffered saline (PBS) and genotyped based on their Venus fluorescence, using an inverted epifluorecence microscope (Leica MZ10F). The embryos were transferred with 100 - 150 µl of enriched medium to the center of a 35-mm glass-bottom dish (hole size 27 mm; Matsunami) and mixed with 100-150 µl of type I collagen-gel solution (Cellmatrix IA; Nitta Gelatin). The solution had been previously diluted to 0.5-0.6 mg/ml with distilled water, 5× DMEM, and a neutralizing buffer, with a final concentration about 0.3 mg/ml, according to the manufacturer's protocol. The gel was incubated at 37°C for 20 minutes. Once the gel was solidified, up to 600 μl of imaging culture medium was gently added to the gel. The final concentration of the culture medium was as follows: DMEM/F-12 (1:1), glucose (0.6%), L-glutamine (2 mM), sodium bicarbonate (3 mM), HEPES buffer (50 mM), insulin (25 μg/ml), transferrin (100 μg/ml), progesterone (20 nM), sodium selenate (30 nM), and putrescine (60 μM), with equilibration buffer supplemented with 4% fetal bovine serum. The dish was attached to a pre-heated microscope stage and incubated at 37°C in 5% CO2. Imaging was carried out with an epifluorescence microscope from Keyence (BZ9000) or a confocal Carl Zeiss microscope (LSM5 PASCAL Exciter). Images were acquired with a 10× objective lens every 10 or 20 minutes, and processed using the Keyence Bz-II application and Zeiss LSM5 software, respectively. NIH ImageJ 1.44e and Quicktime Pro 7.6.8 were used for preparing movie files.

Spinal cord injury model

Adult female Sox10- Venus mice (8-weeks old, n = 4 for each time point) were anesthetized with an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). The dorsal surface of the dura mater was exposed after laminectomy at the tenth thoracic vertebra, and SCI was induced using an IH (Infinite Horizon) impactor (60 kDyn; Precision Systems & Instrumentation) as described previously [46, 47]. The mice were returned to their home cages with free access to water and food. Intact mice and mice at 4 and 14 days post-injury (dpi) were deeply anesthetized and transcardially perfused with chilled PBS followed by 4% paraformaldehyde (PFA). The spinal cords were removed and immersed in 4% PFA at 4°C overnight, and then immersed in 15% and 30% sucrose for 24 hours each, at 4°C. The spinal cords were then embedded in OCT compound and sectioned into 12-µm-thick sagittal sections by cryostat (Leica CM3000).

Abbreviations

NC: 

neural crest

OPC: 

oligodendrocyte progenitor cell

HMG: 

high mobility group

PNS: 

peripheral nervous system

CNS: 

central nervous system

P0: 

protein zero

EGFP: 

enhanced green fluorescent protein

CNP: 

2'-3'-cyclic nucleotide 3'-phosphodiesterase

PLP: 

myelin proteolipid protein

TH: 

tyrosine hydroxylase

DRG: 

dorsal root ganglia

SCI: 

spinal cord injury

DPI: 

days-post-injury

p75: 

p75 neurotrophin receptor

NSPC: 

neural stem/progenitor cell

NCSCs: 

neural crest stem cells

PBS: 

phosphate buffered saline.

Declarations

Acknowledgements

We are grateful to Dr. R.B. Darnell for the gift of the anti-Hu antibody. We are grateful to Drs. C. Hara, N. Kishi, N. Shimojima, M. Mori, A. Iwanami, and H. Kanki for their excellent technical instruction and for critical reading of the manuscript. We also thank all the members in the Okano Laboratory and Akazawa Laboratory for their encouragement and invaluable comments on this manuscript.

This work was supported by a Grant-in-Aid for Young Scientists and a Grant-in-Aid for Scientific Research (C) from The Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) to S.S. and F.R-M.; by a Keio University Grant-in-Aid for the Encouragement of Young Medical Scientists to S.S. and F.R-M.; by Keio Gijuku Academic Development Funds to S.S.; by a JST-SORST fellowship to F.R-M.; by grants from Research Foundation ITSUU Laboratory and Takeda Science Foundation to T. I.; and by a Grant-in-Aid from the Global COE Program of the MEXT to Keio University to H.O.

Authors’ Affiliations

(1)
Department of Physiology, Keio University School of Medicine
(2)
Department of Orthopaedic Surgery, Keio University School of Medicine
(3)
Clinical Research Center, National Hospital Organization, Murayama Medical Center
(4)
Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP
(5)
Department of Biochemistry and Biophysics, Graduate School of Health and Sciences, Tokyo Medical and Dental University

References

  1. Le Douarin NM, Kalcheim C: The Neural Crest. 1999, New York, NY: Cambridge University Press, 2View ArticleGoogle Scholar
  2. Le Douarin NM, Creuzet S, Couly G, Dupin E: Neural crest cell plasticity and its limits. Development. 2004, 131: 4637-4650. 10.1242/dev.01350.View ArticlePubMedGoogle Scholar
  3. Le Douarin NM, Dupin E: Multipotentiality of the neural crest. Curr Opin Genet Dev. 2003, 13: 529-536. 10.1016/j.gde.2003.08.002.View ArticlePubMedGoogle Scholar
  4. Morikawa S, Mabuchi Y, Niibe K, Suzuki S, Nagoshi N, Sunabori T, Shimmura S, Nagai Y, Nakagawa T, Okano H, Matsuzaki Y: Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun. 2009, 379: 1114-1119. 10.1016/j.bbrc.2009.01.031.View ArticlePubMedGoogle Scholar
  5. Nagoshi N, Shibata S, Kubota Y, Nakamura M, Nagai Y, Satoh E, Morikawa S, Okada Y, Mabuchi Y, Katoh H, et al: Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell. 2008, 2: 392-403. 10.1016/j.stem.2008.03.005.View ArticlePubMedGoogle Scholar
  6. Bowles J, Schepers G, Koopman P: Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol. 2000, 227: 239-255. 10.1006/dbio.2000.9883.View ArticlePubMedGoogle Scholar
  7. Wegner M: From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999, 27: 1409-1420. 10.1093/nar/27.6.1409.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Haldin CE, LaBonne C: SoxE factors as multifunctional neural crest regulatory factors. Int J Biochem Cell Biol. 2010, 42: 441-444. 10.1016/j.biocel.2009.11.014.PubMed CentralView ArticlePubMedGoogle Scholar
  9. Kuhlbrodt K, Schmidt C, Sock E, Pingault V, Bondurand N, Goossens M, Wegner M: Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients. J Biol Chem. 1998, 273: 23033-23038. 10.1074/jbc.273.36.23033.View ArticlePubMedGoogle Scholar
  10. Southard-Smith EM, Kos L, Pavan WJ: Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet. 1998, 18: 60-64. 10.1038/ng0198-60.View ArticlePubMedGoogle Scholar
  11. Inoue K, Khajavi M, Ohyama T, Hirabayashi S, Wilson J, Reggin JD, Mancias P, Butler IJ, Wilkinson MF, Wegner M, Lupski JR: Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet. 2004, 36: 361-369. 10.1038/ng1322.View ArticlePubMedGoogle Scholar
  12. Inoue K, Tanabe Y, Lupski JR: Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann Neurol. 1999, 46: 313-318. 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7.View ArticlePubMedGoogle Scholar
  13. Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Prehu MO, Puliti A, Herbarth B, Hermans-Borgmeyer I, Legius E, Matthijs G, et al: SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet. 1998, 18: 171-173. 10.1038/ng0298-171.View ArticlePubMedGoogle Scholar
  14. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP: Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol. 1998, 8: 1323-1326. 10.1016/S0960-9822(07)00562-3.View ArticlePubMedGoogle Scholar
  15. Yamauchi Y, Abe K, Mantani A, Hitoshi Y, Suzuki M, Osuzu F, Kuratani S, Yamamura K: A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev Biol. 1999, 212: 191-203. 10.1006/dbio.1999.9323.View ArticlePubMedGoogle Scholar
  16. Pietri T, Eder O, Blanche M, Thiery JP, Dufour S: The human tissue plasminogen activator-Cre mouse: a new tool for targeting specifically neural crest cells and their derivatives in vivo. Dev Biol. 2003, 259: 176-187. 10.1016/S0012-1606(03)00175-1.View ArticlePubMedGoogle Scholar
  17. Soriano P: Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999, 21: 70-71. 10.1038/5007.View ArticlePubMedGoogle Scholar
  18. Kawamoto S, Niwa H, Tashiro F, Sano S, Kondoh G, Takeda J, Tabayashi K, Miyazaki J: A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett. 2000, 470: 263-268. 10.1016/S0014-5793(00)01338-7.View ArticlePubMedGoogle Scholar
  19. Yoshida S, Shimmura S, Nagoshi N, Fukuda K, Matsuzaki Y, Okano H, Tsubota K: Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea. Stem Cells. 2006, 24: 2714-2722. 10.1634/stemcells.2006-0156.View ArticlePubMedGoogle Scholar
  20. Tomita Y, Matsumura K, Wakamatsu Y, Matsuzaki Y, Shibuya I, Kawaguchi H, Ieda M, Kanakubo S, Shimazaki T, Ogawa S, et al: Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol. 2005, 170: 1135-1146. 10.1083/jcb.200504061.PubMed CentralView ArticlePubMedGoogle Scholar
  21. Aihara Y, Hayashi Y, Hirata M, Ariki N, Shibata S, Nagoshi N, Nakanishi M, Ohnuma K, Warashina M, Michiue T, et al: Induction of neural crest cells from mouse embryonic stem cells in a serum-free monolayer culture. Int J Dev Biol. 2010, 54: 1287-1294. 10.1387/ijdb.103173ya.View ArticlePubMedGoogle Scholar
  22. Mallon BS, Shick HE, Kidd GJ, Macklin WB: Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci. 2002, 22: 876-885.PubMedGoogle Scholar
  23. Yuan X, Chittajallu R, Belachew S, Anderson S, McBain CJ, Gallo V: Expression of the green fluorescent protein in the oligodendrocyte lineage: A transgenic mouse for developmental and physiological studies. Journal of Neuroscience Research. 2002, 70: 529-545. 10.1002/jnr.10368.View ArticlePubMedGoogle Scholar
  24. Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA, Birchmeier C, Wegner M: The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 2001, 15: 66-78. 10.1101/gad.186601.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Ludwig A, Schlierf B, Schardt A, Nave KA, Wegner M: Sox10-rtTA mouse line for tetracycline-inducible expression of transgenes in neural crest cells and oligodendrocytes. genesis. 2004, 40: 171-175. 10.1002/gene.20083.View ArticlePubMedGoogle Scholar
  26. Stine ZE, Huynh JL, Loftus SK, Gorkin DU, Salmasi AH, Novak T, Purves T, Miller RA, Antonellis A, Gearhart JP, et al: Oligodendroglial and pan-neural crest expression of Cre recombinase directed bySox10enhancer. genesis. 2009, 47: 765-770. 10.1002/dvg.20559.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A: A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol. 2002, 20: 87-90. 10.1038/nbt0102-87.View ArticlePubMedGoogle Scholar
  28. Breuskin I, Bodson M, Thelen N, Thiry M, Borgs L, Nguyen L, Lefebvre PP, Malgrange B: Sox10 promotes the survival of cochlear progenitors during the establishment of the organ of Corti. Developmental Biology. 2009, 335: 327-339. 10.1016/j.ydbio.2009.09.007.View ArticlePubMedGoogle Scholar
  29. Breuskin I, Bodson M, Thelen N, Thiry M, Borgs L, Nguyen L, Stolt C, Wegner M, Lefebvre PP, Malgrange B: Glial but not neuronal development in the cochleo-vestibular ganglion requires Sox10. J Neurochem. 2010, 114: 1827-1839. 10.1111/j.1471-4159.2010.06897.x.View ArticlePubMedGoogle Scholar
  30. Lytle JM, Chittajallu R, Wrathall JR, Gallo V: NG2 cell response in the CNP-EGFP mouse after contusive spinal cord injury. Glia. 2009, 57: 270-285. 10.1002/glia.20755.PubMed CentralView ArticlePubMedGoogle Scholar
  31. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, Boussadia O, Kemler R: Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 2001, 128: 1253-1264.PubMedGoogle Scholar
  32. Chai Y, Jiang X, Ito Y, Bringas P, Han J, Rowitch DH, Soriano P, McMahon AP, Sucov HM: Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development. 2000, 127: 1671-1679.PubMedGoogle Scholar
  33. Kirby BB, Takada N, Latimer AJ, Shin J, Carney TJ, Kelsh RN, Appel B: In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development. Nature Neuroscience. 2006, 9: 1506-1511. 10.1038/nn1803.View ArticlePubMedGoogle Scholar
  34. Takada N, Kucenas S, Appel B: Sox10 is necessary for oligodendrocyte survival following axon wrapping. Glia. 2010, 58: 996-1006.PubMed CentralPubMedGoogle Scholar
  35. Crane JF, Trainor PA: Neural crest stem and progenitor cells. Annu Rev Cell Dev Biol. 2006, 22: 267-286. 10.1146/annurev.cellbio.22.010305.103814.View ArticlePubMedGoogle Scholar
  36. Delfino-Machin M, Chipperfield TR, Rodrigues FS, Kelsh RN: The proliferating field of neural crest stem cells. Dev Dyn. 2007, 236: 3242-3254. 10.1002/dvdy.21314.View ArticlePubMedGoogle Scholar
  37. Aki R, Amoh Y, Li L, Katsuoka K, Hoffman RM: Nestin-expressing interfollicular blood vessel network contributes to skin transplant survival and wound healing. J Cell Biochem. 2010, 110: 80-86.PubMedGoogle Scholar
  38. Jinno H, Morozova O, Jones KL, Biernaskie JA, Paris M, Hosokawa R, Rudnicki MA, Chai Y, Rossi F, Marra MA, Miller FD: Convergent Genesis of an Adult Neural Crest-Like Dermal Stem Cell From Distinct Developmental Origins. Stem Cells. 2010,Google Scholar
  39. Amoh Y, Li L, Katsuoka K, Hoffman RM: Multipotent hair follicle stem cells promote repair of spinal cord injury and recovery of walking function. Cell Cycle. 2008, 7: 1865-1869.View ArticlePubMedGoogle Scholar
  40. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA, Copeland NG: A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 2001, 73: 56-65. 10.1006/geno.2000.6451.View ArticlePubMedGoogle Scholar
  41. Inoue T, Inoue YU, Asami J, Izumi H, Nakamura S, Krumlauf R: Analysis of mouse Cdh6 gene regulation by transgenesis of modified bacterial artificial chromosomes. Dev Biol. 2008, 315: 506-520. 10.1016/j.ydbio.2007.12.011.View ArticlePubMedGoogle Scholar
  42. Sakakibara S, Nakamura Y, Satoh H, Okano H: Rna-binding protein Musashi2: developmentally regulated expression in neural precursor cells and subpopulations of neurons in mammalian CNS. J Neurosci. 2001, 21: 8091-8107.PubMedGoogle Scholar
  43. Sakakibara S, Nakamura Y, Yoshida T, Shibata S, Koike M, Takano H, Ueda S, Uchiyama Y, Noda T, Okano H: RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. Proc Natl Acad Sci USA. 2002, 99: 15194-15199. 10.1073/pnas.232087499.PubMed CentralView ArticlePubMedGoogle Scholar
  44. Miyata T, Nakajima K, Mikoshiba K, Ogawa M: Regulation of Purkinje cell alignment by reelin as revealed with CR-50 antibody. J Neurosci. 1997, 17: 3599-3609.PubMedGoogle Scholar
  45. Miyata T, Ogawa M: Twisting of neocortical progenitor cells underlies a spring-like mechanism for daughter-cell migration. Curr Biol. 2007, 17: 146-151. 10.1016/j.cub.2006.11.023.View ArticlePubMedGoogle Scholar
  46. Kumagai G, Okada Y, Yamane J, Nagoshi N, Kitamura K, Mukaino M, Tsuji O, Fujiyoshi K, Katoh H, Okada S, et al: Roles of ES cell-derived gliogenic neural stem/progenitor cells in functional recovery after spinal cord injury. PLoS One. 2009, 4: e7706-10.1371/journal.pone.0007706.PubMed CentralView ArticlePubMedGoogle Scholar
  47. Scheff SW, Rabchevsky AG, Fugaccia I, Main JA, Lumpp JE: Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J Neurotrauma. 2003, 20: 179-193. 10.1089/08977150360547099.View ArticlePubMedGoogle Scholar

Copyright

© Shibata et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement